Press Releases Qiagen N.V.

Equities

QGEN

NL0015001WM6

Market Closed - Nyse Other stock markets 01:30:02 03/05/2024 am IST			5-day change	1st Jan Change
42.68 ^USD	-0.30%		+2.79%	-4.68%

30/04	QIAGEN NV : Berenberg reaffirms its Buy rating	ZD
30/04	QIAGEN : A decent start to 2024; guidance unchanged

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

QIAGEN enhances bioinformatics workflows with new secondary analysis solution for oncology and inherited disease applications	03/05	AQ
Qiagen N : First Quarter 2024 SEC Filing	02/05	PU
Q1 2024 Results Conference Call Presentation: April 30, 2023	30/04	PU
Qiagen N : QIAGEN reports results for Q1 2024 ahead of outlook, on track to achieve full-year 2024 guidance	30/04	PU
Q1 2024 Results Press Release: April 29, 2024, 22:05 CET	30/04	PU
Qiagen: Q1 Earnings Snapshot	30/04	AQ
QIAGEN reports results for Q1 2024 ahead of outlook, on track to achieve full-year 2024 guidance	30/04	AQ
Qiagen N : 2023 Annual Report 2023 IFRS Annual Report	25/04	PU
QIAGEN expands tuberculosis portfolio with new NGS Panel to support real-time surveillance and combat antimicrobial resistance	25/04	AQ
QIAGEN N.V. to release results for Q1 2024 and hold webcast	09/04	AQ
Qiagen N : launches new solution for screening of sexual assault forensic casework samples	04/04	PU
QIAGEN strengthens its portfolio for cancer research, showcasing latest product launches at AACR Annual Meeting 2024	04/04	AQ
QIAGEN introduces QIAstat-Dx Analyzer 2.0 with remote test results access, enhancing collaboration across healthcare system	26/03	AQ
QIAGEN partners with International Panel Physicians Association to increase awareness of tuberculosis screening requirements	19/03	AQ
Qiagen N : Virtual Exane Conference Investor Introduction	12/03	PU
Qiagen N : TD Cowen Healthcare Conference March 5-6 Investor Introduction	12/03	PU
QIAGEN announces Form 20-F annual report filing for 2023 results	11/03	AQ
For the UK: QIAGEN Ltd statement about the Modern Slavery Act 2015 for 2024	06/03	PU
QIAGEN launches AI-derived biomedical knowledge base to accelerate data-driven drug discovery	28/02	AQ
QIAGEN earns ACT Label for new eco-friendlier QIAwave products and achieves first My Green Lab Platinum certification	28/02	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

QIAGEN : A decent start to 2024; guidance unchanged

April 30, 2024 at 07:02 pm IST